{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:48:32Z","timestamp":1793969312022,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K11626"],"award-info":[{"award-number":["JP20K11626"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e17588","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T22:28:48Z","timestamp":1687645728000},"page":"e17588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Kaempferia galanga L. extract and its main component, ethyl p-methoxycinnamate, inhibit the proliferation of Ehrlich ascites tumor cells by suppressing TFAM expression"],"prefix":"10.1016","volume":"9","author":[{"given":"Yutaro","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Norikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Matsui-Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1492-109X","authenticated-orcid":false,"given":"Ritsuko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-8178","authenticated-orcid":false,"given":"Leenawaty","family":"Limantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8167-3693","authenticated-orcid":false,"given":"Akiko","family":"Kojima-Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2023.e17588_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e17588_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/1061186X.2013.837469","article-title":"Nanotechnology in cancer therapy","volume":"21","author":"Aslan","year":"2013","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17588_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e17588_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chempr.2018.01.012","article-title":"Bioactive compound collections: from design to target identification","volume":"4","author":"Laraia","year":"2018","journal-title":"Chem"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e17588_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jep.2005.05.011","article-title":"Plants as a source of anti-cancer agents","volume":"100","author":"Cragg","year":"2005","journal-title":"J. Ethnopharmacol."},{"issue":"23\u201324","key":"10.1016\/j.heliyon.2023.e17588_bib6","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.drudis.2009.09.006","article-title":"Anticancer drug discovery in the future: an evolutionary perspective","volume":"14","author":"Ma","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2023.e17588_bib7","article-title":"Kaempferia galanga L.: progresses in phytochemistry, pharmacology, toxicology and ethnomedicinal uses","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"sup1","key":"10.1016\/j.heliyon.2023.e17588_bib8","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/10942912.2017.1286508","article-title":"Antioxidant properties of ginger (Kaempferia angustifolia Rosc.) and its chemical markers","volume":"20","author":"Yeap","year":"2017","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.heliyon.2023.e17588_bib9","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2147\/JIR.S359042","article-title":"Anti-inflammatory activity and wound healing effect of Kaempferia galanga L. Rhizome on the chemical-induced oral mucosal ulcer in wistar rats","volume":"15","author":"Wahyuni","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17588_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jksus.2017.05.009","article-title":"Antioxidant and antineoplastic activities of methanolic extract of Kaempferia galanga Linn. Rhizome against Ehrlich ascites carcinoma cells","volume":"30","author":"Ali","year":"2018","journal-title":"J. King Saud Univ. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/1755-1315\/819\/1\/012057","article-title":"Chemical component of kencur (kaemferia galanga L.) ethanolic extract using gas chromatography-mass spectrometry","volume":"819","author":"Hikmawanti","year":"2021","journal-title":"IOP Conf. Ser. Earth Environ. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17588_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6061\/clinics\/2014(02)10","article-title":"Ethyl-p-methoxycinnamate isolated from Kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-\u03b1, and angiogenesis by blocking endothelial functions","volume":"69","author":"Umar","year":"2014","journal-title":"Clinics"},{"key":"10.1016\/j.heliyon.2023.e17588_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113911","article-title":"Standardization of Kaempferia galanga L. rhizome and vasorelaxation effect of its key metabolite ethyl p-methoxycinnamate","volume":"271","author":"Srivastava","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17588_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.fitote.2011.03.006","article-title":"Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitro","volume":"82","author":"Lakshmanan","year":"2011","journal-title":"Fitoterapia"},{"key":"10.1016\/j.heliyon.2023.e17588_bib15","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.13005\/ojc\/320547","article-title":"Cytotoxicity activity of biotransformed ethyl p-methoxycinnamate by Aspergillus Niger","volume":"32","author":"Omar","year":"2016","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.heliyon.2023.e17588_bib16","first-page":"2115","article-title":"Anti-neoplastic potential of ethyl-p-methoxycinnamate of Kaempferia galanga on oral cancer cell lines","volume":"16","author":"Ichwan","year":"2019","journal-title":"Mater. Today: Proc."},{"issue":"5008","key":"10.1016\/j.heliyon.2023.e17588_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.2035027","article-title":"Similarity of human mitochondrial transcription factor 1 to high mobility group proteins","volume":"252","author":"Parisi","year":"1991","journal-title":"Sci"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17588_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/1873-3468.12989","article-title":"The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms","volume":"592","author":"Kang","year":"2018","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2011.03.114","article-title":"Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth","volume":"408","author":"Han","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cvr\/cvq374","article-title":"Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription","volume":"90","author":"Watanabe","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17588_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/dna.2013.2132","article-title":"microRNA-200a inhibits cell proliferation by targeting mitochondrial transcription factor A in breast cancer","volume":"33","author":"Yao","year":"2014","journal-title":"DNA Cell Biol."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e17588_bib23","first-page":"2375","article-title":"Ehrlich ascites carcinoma","volume":"10","author":"Ozaslan","year":"2011","journal-title":"Afr. J. Biotechnol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17588_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3177\/jnsv.53.540","article-title":"Mechanism of growth inhibitory effect of cape aloe extract in Ehrlich ascites tumor cells","volume":"53","author":"Kametani","year":"2007","journal-title":"J. Nutr. Sci. Vitaminol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12906-017-1713-4","article-title":"Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract","volume":"17","author":"Amuamuta","year":"2017","journal-title":"BMC Compl. Alternative Med."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e17588_bib26","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","article-title":"Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17588_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1097-2765(00)80308-1","article-title":"Ras enhances Myc protein stability","volume":"3","author":"Sears","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2023.e17588_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08815","article-title":"Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: a comprehensive review","author":"Sohel","year":"2022","journal-title":"Heliyon"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e17588_bib29","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1007\/s00018-013-1302-8","article-title":"Cell cycle progression by the repression of primary cilia formation in proliferating cells","volume":"70","author":"Goto","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17588_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1289\/ehp.93101s59","article-title":"Cell cycle controls: potential targets for chemical carcinogens?","volume":"101","author":"Afshari","year":"1993","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib31","first-page":"94","article-title":"Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy","volume":"27","author":"Wu","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.heliyon.2023.e17588_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/361020","article-title":"CDK\/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity","volume":"2014","author":"Bonelli","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e17588_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of cell cycle transcription during G1 and S phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17588_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/cbt.72","article-title":"Cycling to cancer with cyclin D1","volume":"1","author":"Diehl","year":"2002","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e17588_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/gad.11.7.847","article-title":"New functional activities for the p21 family of CDK inhibitors","volume":"11","author":"LaBaer","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.heliyon.2023.e17588_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12935-018-0595-y","article-title":"The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells","volume":"18","author":"Gao","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e17588_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mito.2006.11.017","article-title":"Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions","volume":"7","author":"Kang","year":"2007","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17588_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tibs.2007.01.003","article-title":"Mitochondrial transcription and its regulation in mammalian cells","volume":"32","author":"Asin-Cayuela","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.heliyon.2023.e17588_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-018-0011-z","article-title":"Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer","volume":"3","author":"Sun","year":"2018","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e17588_bib40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/life11090950","article-title":"Hesperidin and chlorogenic acid synergistically inhibit the growth of breast cancer cells via estrogen receptor\/mitochondrial pathway","volume":"11","author":"Hsu","year":"2021","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17588_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbrc.2012.11.096","article-title":"p21(WAF1\/C1P1) deficiency induces mitochondrial dysfunction in HCT116 colon cancer cells","volume":"430","author":"Kim","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"sup1","key":"10.1016\/j.heliyon.2023.e17588_bib42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/21691401.2018.1431654","article-title":"KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM","volume":"46","author":"Chen","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e17588_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4314\/tjpr.v16i6.8","article-title":"Mitochondrial transcription factor A protects human retinal endothelial cell injury induced by hypoxia","volume":"16","author":"Xie","year":"2017","journal-title":"Trop. J. Pharmaceut. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17588_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000013","article-title":"Sensing and integration of erk and PI3K signals by myc","volume":"4","author":"Lee","year":"2008","journal-title":"PLoS Comput. Biol."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e17588_bib46","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1101\/gad.836800","article-title":"Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability","volume":"14","author":"Sears","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.heliyon.2023.e17588_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.02.029","article-title":"Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice","volume":"285","author":"Donia","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e17588_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-14770-1","article-title":"Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice","volume":"12","author":"Morsi","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e17588_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"6550","key":"10.1016\/j.heliyon.2023.e17588_bib50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/377649a0","article-title":"Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin","volume":"377","author":"Takahara","year":"1995","journal-title":"Nat"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e17588_bib51","first-page":"901","article-title":"Mechanisms of the CDK4\/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment","volume":"39","author":"Liu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e17588_bib52","first-page":"361","article-title":"Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis","volume":"33","author":"Tanaka","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e17588_bib53","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.1111\/j.1742-4658.2007.06167.x","article-title":"Human mitochondrial transcription factor A possesses multiple subcellular targeting signals","volume":"274","author":"Pastukh","year":"2007","journal-title":"FEBS J."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023047965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023047965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:24:34Z","timestamp":1790468674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023047965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023047965"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17588","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kaempferia galanga L. extract and its main component, ethyl p-methoxycinnamate, inhibit the proliferation of Ehrlich ascites tumor cells by suppressing TFAM expression","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e17588"}}